Conference Support for Rare Neurodevelopmental Disorder Communities Participating in Simons Searchlight - Tier 1 Grant
Funding Amount
Up to US $2,500
Deadline
Deadline not published
Grant Type
Foundation
Can we apply?
Check your organization against each line. Taken from the listing; confirm with the funder's guidelines.
Required status
- 501(c)(3) tax-exempt status
Other requirements
- Applicants should be patient advocacy groups (PAGs) for Simons Searchlight Gene/CNV groups who use Simons Searchlight as their major registry.
- Conferences must be scheduled to occur between January 2025 and February 2026.
- Depending on the date of your conference, payments may be issued retroactively.
- We welcome applications for conferences held and/or organized by groups both in and outside the United States.
Overview
The Simons Foundation is offering funding for Patient Advocacy Group Family Conferences aimed at communities involved in Simons Searchlight. This initiative supports both established and emerging groups, enhancing research engagement through scientist presentations and in-person opportunities. The funding, starting at $2,500 for Tier 1, is available for conferences scheduled between January 2025 and February 2026, encouraging connections between families and researchers to facilitate impactful dialogue.
Conference Support for Rare Neurodevelopmental Disorder Communities Participating in Simons Searchlight
SFARI is accepting applications for funding of Patient Advocacy Group Family Conferences, with a focus on groups in the Simons Searchlight community. This funding is intended to support and enhance the research component of conferences, from scientist presentations to in-person research opportunities for families. It is open to both patient advocacy groups (PAGs) with well-established conferences as well as those in early years of convening families and connecting to science.
SFARI Mission
SFARI’s mission is to improve the understanding, diagnosis, and treatment of autism spectrum disorders by funding innovative research of the highest quality and relevance.
Opportunity
SFARI is accepting applications for funding of Patient Advocacy Group Family Conferences, with a focus on groups in the Simons Searchlight community. This funding is intended to support and enhance the research component of conferences, from scientist presentations to in-person research opportunities for families. It is open to both patient advocacy groups (PAGs) with well-established conferences as well as those in early years of convening families and connecting to science.
Tier 1: $2,500
Tier 1 funding is intended for groups that are just getting started and plan to use the meeting to mobilize their community. Applicant groups are not required to have a full scientific meeting agenda in place at the time of application but are encouraged to plan for a scientific component to their in-person meeting.
This is also the funding tier for groups with significant research agendas but for which researchers will present remotely to the in-person conference.
Eligibility
Applicants should be patient advocacy groups (PAGs) for Simons Searchlight Gene/CNV groups who use Simons Searchlight as their major registry. Conferences must be scheduled to occur between January 2025 and February 2026. Depending on the date of your conference, payments may be issued retroactively. We welcome applications for conferences held and/or organized by groups both in and outside the United States. Groups in the United States must have 501(c)(3) nonprofit status; international organizations will be required to be deemed the equivalent of a U.S. public charity via requested documentation or the completion of an equivalency determination.
What The Simons Foundation Inc actually gave
Source: IRS Form 990-PF, 2024
- Grants in 2024
- 1,727
- Total given
- $271.96M
- Median grant
- $72K
- Range
- $1,480–$20M
- By dollars: New York 31%, California 16%, Massachusetts 13%. Top recipient cities: New York, NY; Cambridge, MA; Chicago, IL.
- <1% of grants with a stated purpose were for general or operating support.
- 34% of recipients were new grantees, not repeat recipients.
Example grants
New York Genome Center · New York, NY
New york genome center 2018 "new gift"
$20M
Stony Brook Foundation · Stony Brook, NY
Simons infinity investment matching gift
$6.67M
University of Edinburgh
A major programme of fundamental and clinical autism research
$5.15M
New York University · New York, NY
Simons center for computational physical chemistry
$4.43M
Clinical Research Associates · New York, NY
Autism research
$4.23M
Focus Areas & Funding Uses
Fields of Work
- Developmental disabilities
- Autism
Categories
Browse similar grants by category
Related Grants
Open grants from this funder and similar programs
Simons Historically Black Colleges and Universities Faculty Fellowship
The Simons Foundation Inc
Amount
Up to $1.6M
Deadline
November 12, 2026
Listed date — confirm with the funder
Simons Centers of Excellence at Historically Black Colleges and Universities
The Simons Foundation Inc
Amount
Up to $7.5M
Deadline
November 12, 2026
Listed date — confirm with the funder
SPARK Research Match Expansion RFA Grant
The Simons Foundation Inc
Amount
Up to US $10,000
Deadline
Deadline not published
Shenoy Undergraduate Research Fellowship in Neuroscience Grant
The Simons Foundation Inc
Amount
Up to US $11,500
Deadline
Deadline not published
Simons Graduate Fellowships in Ecology and Evolution Grant
The Simons Foundation Inc
Amount
US $265,800
Deadline
Deadline not published
Simons Foundation Autism & Neuroscience Conferences and Courses Awards Grant
The Simons Foundation Inc
Amount
More than US $75,000
Deadline
Deadline not published
Ready to apply for Conference Support for Rare Neurodevelopmental Disorder Communities Participating in Simons Searchlight - Tier 1 Grant?
Grantable helps you assess fit, draft narratives, and track deadlines — so you can submit stronger applications, faster.
You found Conference Support for Rare Neurodevelopmental Disorder Communities Participating in Simons Searchlight - Tier 1 Grant. Now let's win it.